EP01.07-004 FDG-PET-CT for Staging Screen Detected Lung Cancer

Abstract

As lung cancer screening programs develop globally, concern for increasing downstream investigations and cost remain. Flurodeoxyglucose positron emission tomography computed tomography (FDG-PET-CT) is routinely conducted for pre-operative staging, however its utility in screen detected lung cancer is unclear. PET-CT increases the wait time from tissue diagnosis to surgery as well as adds cost. We hypothesize for screen detected early-stage lung cancer (cT1a), PET-CT will not significantly change peri-operative management beyond clinical staging with traditional CT and linear endobronchial ultrasound staging (EBUS).